---
$id: https://graph.org.ai/products/commodity/51161718
$type: Product
source: UNSPSC
code: "51161718"
title: "Pentetrazol"
class: "51161700"
classTitle: "Drugs used for respiratory tract disorders"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pentetrazol

**UNSPSC Code**: 51161718
**Class**: [Drugs used for respiratory tract disorders](Drugs used for respiratory tract disorders.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a convulsant and gaba antagonist with the molecular formula C6H10N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WM5Z385K7T, chemically known as 7,8,9,10-tetrazabicyclo(5.3.0)-8,10-decadiene but generally known as pentetrazol, which bears US NIH Compound Identifier 5917. European Medicines Agency schedules Pentetrazol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09690MIG. World Health Organization schedules pentetrazol in its Anatomical Therapeutic Chemical (ATC) Classification. PENTETRAZOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pentetrazol under HS 29339990 and SITC 51577. As of Q4 2014, PENTETRAZOL remains the US FDA Preferred Term for this commodity. Pentetrazol bears US NLM identifiers UMLS ID C0030903 and NCI Concept Code C81054. SMILES: C1CCC2=NN=NN2CC1.

